Literature DB >> 15241139

Twenty-year evaluation of cementless mobile-bearing total ankle replacements.

Frederick F Buechel1, Frederick F Buechel1, Michael J Pappas.   

Abstract

Two consecutive series of patients who had cementless, porous-coated, congruent-contact, mobile-bearing total ankle replacements were evaluated during a 20-year interval using the New Jersey Orthopaedic Hospital ankle scoring scale to determine clinical outcome and overall implant survivorship with revision as an end point. The initial series of 38 patients (40 ankle replacements) using a shallow-sulcus design had diagnoses of: osteoarthritis, seven (17.5%); rheumatoid arthritis, nine (22.5%); posttraumatic arthritis, 21 (52.5%); and failed fusion, three (7.5%). Clinical results after 2-20 years, (mean, 12 years) were 28 (70%) good to excellent, two (5%) fair, and 10 (25%) poor. Postoperative ankle motion ranged from 10 degrees-47 degrees total arc (mean, 25 degrees total arc). The 20-year overall survivorship for the shallow-sulcus design was 74.2%. A second series of 74 patients (75 ankle replacements) using a deep-sulcus design had diagnoses of: osteoarthritis, eight (11%); rheumatoid arthritis, nine (12%); osteonecrosis, three (4%); and posttraumatic arthritis, 55 (73%). Clinical results after 2-12 years, (mean 5 years) were 66 (88%) good to excellent, four (5%) fair, and five (7%) poor. Postoperative ankle motion ranged from 10 degrees-50 degrees total arc (mean, 29 degrees total arc). The 12-year overall survivorship for the deep-sulcus design was 92%.

Entities:  

Mesh:

Year:  2004        PMID: 15241139     DOI: 10.1097/01.blo.0000132243.41419.59

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  17 in total

Review 1.  Total ankle replacement: why, when and how?

Authors:  Davide Edoardo Bonasia; Federico Dettoni; John E Femino; Phinit Phisitkul; Margherita Germano; Annunziato Amendola
Journal:  Iowa Orthop J       Date:  2010

Review 2.  Total ankle replacement.

Authors:  Alexej Barg; Matthias D Wimmer; Martin Wiewiorski; Dieter C Wirtz; Geert I Pagenstert; Victor Valderrabano
Journal:  Dtsch Arztebl Int       Date:  2015-03-13       Impact factor: 5.594

3.  Medial impingement after ankle replacement.

Authors:  Harish V Kurup; Graeme R Taylor
Journal:  Int Orthop       Date:  2007-01-06       Impact factor: 3.075

Review 4.  [Modern three-piece total ankle replacement. Frequency and causes of luxation and premature wear of the polyethylene bearing].

Authors:  A H Hoffmann; B Fink
Journal:  Orthopade       Date:  2007-10       Impact factor: 1.087

5.  The Salto total ankle arthroplasty: survivorship and analysis of failures at 7 to 11 years.

Authors:  Michel Bonnin; Fabrice Gaudot; Jean-Raphael Laurent; Scott Ellis; Jean-Alain Colombier; Thierry Judet
Journal:  Clin Orthop Relat Res       Date:  2010-07-01       Impact factor: 4.176

6.  Complications and results of the arthrodesis after total ankle arthroplasty failure: a retrospective monocentric study of 12 cases.

Authors:  F Egrise; J Parot; C Bauer; F Galliot; M Kirsch; D Mainard
Journal:  Eur J Orthop Surg Traumatol       Date:  2019-09-28

7.  The AES total ankle arthroplasty analysis of failures and survivorship at ten years.

Authors:  Alexandre Di Iorio; Anthony Viste; Michel Henry Fessy; Jean Luc Besse
Journal:  Int Orthop       Date:  2017-09-04       Impact factor: 3.075

8.  [Foot and ankle surgery].

Authors:  O Niggemeyer; F Moosig; W Rüther
Journal:  Z Rheumatol       Date:  2011-01       Impact factor: 1.372

9.  Arthroplasty versus arthrodesis for end-stage ankle arthritis: decision analysis using Markov model.

Authors:  Dae Gyu Kwon; Chin Youb Chung; Moon Seok Park; Ki Hyuk Sung; Tae Won Kim; Kyoung Min Lee
Journal:  Int Orthop       Date:  2011-08-20       Impact factor: 3.075

Review 10.  How successful are current ankle replacements?: a systematic review of the literature.

Authors:  Nikolaos Gougoulias; Anil Khanna; Nicola Maffulli
Journal:  Clin Orthop Relat Res       Date:  2009-07-18       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.